DNA RNA and Cells
2 December 2015
OncoGenex Announces Phase 3 AFFINITY Trial with Custirsen Continues Following Interim Analyses1 December 2015
Adaptimmune and Universal Cells Announce Collaboration to Develop Allogeneic T-Cell Therapies16 November 2015
MiNA Therapeutics Announces AASLD Liver Meeting Presentation on Lead Program Demonstrating Reversal of Liver Failure in Animal Model16 November 2015
Arrowhead Presents Data Showing Robust Sustained Anti-viral Effects with ARC-520 in Hepatitis B Infected Chimpanzees13 November 2015
miRagen Therapeutics Initiates First Clinical Trial for Anti-Fibrosis Product Candidate MRG-20112 November 2015
Spark Therapeutics Announces SPK-TPP1, Its First Program Targeting Neurodegenerative Disease10 November 2015
Celyad Successfully Completes 30-Day Safety Follow-Up of First Patient Cohort in NKG2D CAR T-Cell Phase I Trial5 November 2015
RXi Pharmaceuticals Announces the Initiation of a Phase 1/2 Trial in Ophthalmology with RXI-109 for Retinal Scarring30 October 2015
Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-FXI Rx in Patients with End-Stage Renal Disease on Hemodialysis29 October 2015
ProNAi Initiates ‘Brighton’ Phase II Trial of PNT2258 in Patients with Richter’s Transformation28 October 2015
Macrocure Ltd. Announces Results for Phase III Clinical Trial of CureXcell(R) in Diabetic Foot Ulcers and Provides Corporate UpdateNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports